The grades of six semiconductor stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.
Top 10 Safest Companies To Watch For 2015: Powershares Golden Dragon (PGJ)
PowerShares Golden Dragon Halter USX China Portfolio is based on the Halter USX China Index. The Index is comprised of the United States listed securities of companies, which derive a majority of their revenue from the People's Republic of China. The fund was incepted on December 9, 2004.
The sectors covered by the investment include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, materials, telecommunications and utilities. PowerShares Capital Management LLC provides investment management to the Fund.
Advisors' Opinion:- [By Robert Martin]
With that in mind, here are four of the best emerging market ETF picks: A China ETF, an India ETF, and two other ETFs that track broad indices like the MSCI Emerging Markets Index.
PowerShares Gold Dragon Halter USX China Portfolio (PGJ)Expense Ratio: 0.7%
- [By MONEYMORNING.COM]
PowerShares Golden Dragon China Portfolio (NYSE: PGJ) has a position in more than 70 companies, and its holdings are all U.S.-listed companies that generate most of their revenue in China. For that reason, Alibaba is the perfect candidate to join PGJ's holdings once it starts trading on the New York Stock Exchange.
Top 10 Dow Dividend Companies To Watch In Right Now: Dynavax Technologies Corporation(DVAX)
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The company's lead product candidate includes HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine designed to provide protection with fewer doses than current licensed vaccines. It also develops Universal Flu vaccine, a Phase 1b clinical trial vaccine for influenza prevention; SD-101, a Phase Ib clinical trial hepatitis C therapy; DV-601, a Phase Ib clinical trial hepatitis B therapy; AZD1419, a preclinical asthma therapy; and DV1179, a Phase 1 trial autoimmune and inflammatory disease therapy. Dynavax Technologies Corporation has strategic alliance with GlaxoSmithKline plc to discover, develop, and commercialize DV1179 and other endosomal toll-like receptor inhibitors for diseases, such as lupus, psoriasis, and rheumatoid arthritis; and develop a TLR8 inhibitor for the treatment of multiple autoimmune and i nflammatory diseases, as well as has research and license agreement with AstraZeneca to discover and develop TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The company was founded in 1996 and is based in Berkeley, California.
Advisors' Opinion:- [By Selena Maranjian]
Among holdings in which Farallon Capital Management increased its stake were Dynavax (NASDAQ: DVAX ) and Freeport McMoRan Copper & Gold (NYSE: FCX ) . Dynavax shares fell sharply upon an FDA rejection of its hepatitis B vaccine Heplisav. It may still win more limited approval, but Dynavax now has more work to do, and it's burning cash while its revenue has been shrinking. Fortunately, it does seem to have have ample cash to keep it afloat for a few years. Meanwhile, Dynavax has a new CEO, and its latest earnings report featured a loss slightly bigger than expected.
Top 10 Dow Dividend Companies To Watch In Right Now: Infoblox Inc (BLOX)
Infoblox Inc. (Infoblox), incorporated in May 2003, is an automated network controller. The Company�� network functions include Internet protocol (IP) address management, device configuration, compliance, network discovery, policy implementation, security and monitoring. The Company�� appliance-based solution combines real-time IP address management with the automation of key network control and network change and configuration management processes in purpose-built physical and virtual appliances. It is based on its software that is scalable and automates vital network functions, such as IP address management, device configuration, compliance, network discovery, policy implementation, security and monitoring. It offers two families of products: Trinzic Enterprise and Trinzic NetMRI. The Trinzic Enterprise product family enables real-time IP address management and automates key network control processes. The Trinzic NetMRI product family automates network change and configuration management processes.
Trinzic Enterprise Family
The Company derives its product revenue from its Trinzic Enterprise family of products. The components of its Trinzic Enterprise family, are Trinzic Enterprise, Trinzic IPAM for Microsoft, Trinzic Reporting and Trinzic IPAM Insight. Its Trinzic Enterprise product is an appliance that is designed to for continuous operation of network control. Trinzic Enterprise offers file delivery services via the File Transfer Protocol (FTP), Trivial File Transfer Protocol (TFTP), and Hypertext Transfer Protocol (HTTP), time synchronization services via the Network Time Protocol (NTP) and Logging services via Syslog.
Trinzic IPAM for Microsoft provides a single, Web-based management interface for the centralized management of DNS, DHCP and multiple IP address pools running on Microsoft servers without any installation of software on Microsoft servers. It also provides Microsoft server management capabilities, such as centralized IP address management! , DNS changes and individualized, role-based access control. Trinzic Reporting provides long-term reporting, trending, analysis and tracking capabilities to report network utilization, isolate performance problems, implement DHCP and DNS capacity planning and identify security threats. Trinzic Reporting automates tasks associated with collecting, tabulating and correlating data and displays the information through its Web-based management interface. Trinzic IPAM Insight allows automated discovery of network device configuration information used in automation and compliance reporting.
Trinzic NetMRI Family
The Company�� Trinzic NetMRI products components of include Trinzic Network Automation, Trinzic Network Compliance, Trinzic Switch Port Manager and Trinzic PCI Insight. Its Trinzic NetMRI product automates network change and configuration management processes. Trinzic NetMRI enables information technology organizations to automate network changes, gain visibility into the impact of changes occurring on the network, manage network configurations, archive network configurations and meet a range of compliance requirements for both physical and virtual machines. Trinzic NetMRI discovers and monitors network infrastructure devices to determine critical network information. It uses this information to analyze network stability, to identify unauthorized devices and to take inventory of network devices for inventory management and/or troubleshooting. Trinzic Network Automation automates network configuration functions.
Trinzic Network Compliance automates the network compliance process, meeting corporate security requirements and providing the necessary information and control for internal and external compliance mandates. Trinzic Network Compliance also automatically alerts IT personnel in the event of a failure to meet compliance guidelines and permits the establishment and deployment of specific end customer requirements with click and drag simplicity, supporting ! complianc! e mandates such as those under the Payment Card Industry Data Security Standard (PCI DSS), the Health Insurance Portability and Accountability Act of 1996 (HIPAA), the Sarbanes-Oxley Act, Federal Energy Regulatory Commission (FERC) and North American Electric Reliability Corporation (NERC).
Trinzic Switch Port Manager enables its end customers to identify the number of switch ports, manage them precisely and locate the next available switch port. It helps provide views and management of switches with both current and historical IP addresses, MAC addresses, VLAN mappings and network device topology information. It also shows where devices have been connected, when they connected and where they are currently connected so that the network administrator can easily track authorized devices and find rogue devices that can pose security risks and create network instability. Trinzic PCI Insight is an integrated offering that bundles Trinzic Network Compliance, Trinzic IPAM Insight from its Trinzic Enterprise family of products and consulting services and enables its end customers to optimize their PCI DSS compliance.
The Company competes with BMC Software, Inc., EMC Corporation, Hewlett-Packard Company and International Business Machines Corporation, Alcatel-Lucent, BT Group plc and BlueCat Networks, Inc.
Advisors' Opinion:- [By Evan Niu, CFA]
What: Shares of Infoblox (NYSE: BLOX ) have popped today by as much as 18% after the company reported earnings.
So what: Revenue in the fiscal third quarter came in at a record $58 million, topping the Street's $56 million forecast. Non-GAAP earnings per share totaled $0.11, also ahead of the $0.06-per-share adjusted profit that investors were expecting. CEO Robert Thomas said the company's value proposition -- helping networks become more automated and secure -- is driving its outperformance.
- [By Mani]
[Related -Infoblox, Inc. (BLOX) Q4 Earnings Preview: What To Watch?]
In the past three quarters, the company's earnings have managed to edge past the Street's view by a wide margin in the range of 50 to 83.3 percent. Perhaps, another nice surprise is on its way.
- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Wednesday’s session are Hewlett-Packard Co.(HPQ), Infoblox Inc.(BLOX), and Tilly's Inc.(TLYS)
- [By Rich Bieglmeier]
[Related -Infoblox Inc (BLOX): Getting off the Mat?]
Infoblox is an automated network controller. The Company's network functions include Internet protocol (IP) address management, device configuration, compliance, network discovery, policy implementation, security and monitoring.
Top 10 Dow Dividend Companies To Watch In Right Now: Maiden Hldgs Ltd(MHLD)
Maiden Holdings, Ltd., through its subsidiaries, provides reinsurance solutions to regional and specialty insurers primarily in the United States and Europe. The company offers property, casualty, accident, and health reinsurance products. It offers its products through the treaties with other insurers on a quota share or excess of loss basis, as well as on a facultative basis through third-party intermediaries and on direct basis. Maiden Holdings, Ltd. was founded in 2007 and is headquartered Hamilton, Bermuda.
Advisors' Opinion:- [By Marc Bastow]
Bermuda-based reinsurance solutions provider Maiden Holdings (MHLD) raised its quarterly dividend 22% to 11 cents per share, payable on Jan. 15 to shareholders of record as of Jan. 2.
MHLD Dividend Yield: 3.79%
Top 10 Dow Dividend Companies To Watch In Right Now: Keryx Biopharmaceuticals Inc.(KERX)
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment cancer and renal disease. The company?s products under development include KRX-0401 (perifosine), an oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, as well as affects other pathways associated with programmed cell death, cell growth, cell differentiation, and cell survival. Its KRX-0401 is in Phase III clinical development stage for the treatment of refractory advanced colorectal cancer and multiple myeloma, as well as in Phase I and Phase II clinical development stages for the treatment of other tumor types. The company is also developing Zerenex (ferric citrate), an oral, ferric iron-based compound that is in Phase III clinical development for the treatment of hyperphosphatemia in patients with end-stage renal disease o n dialysis. Keryx Biopharmaceuticals, Inc. has commercial license agreements with Zentaris AG for the development of KRX-0401; Panion & BF Biotech, Inc. for the development and marketing of Zerenex; and Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Zerenex in Japan. The company was founded in 1997 and is based in New York, New York.
Advisors' Opinion:- [By StockMatusow]
Keryx Biopharmaceuticals (KERX) is another company which did an offering that was received very well by investors. Keryx is a company that works on developing and commercializing novel therapies for the treatment of renal disease. On January 30, 2013, Keryx offered 8,234,000 shares priced at $8.49 per share. The offering was quickly bought by investors and continued to run higher.
- [By gurujx]
Keryx Biopharmaceuticals Inc. (KERX): CFO James F. Oliviero III Sold 109,500 Shares
CFO�James F. Oliviero III�sold 109,500 shares of KERX stock on 12/30/2013 at the average price of $12.64. James F. Oliviero III owns at least 476,429 shares after this. The price of the stock has decreased by 3.32% since.
- [By Keith Speights and Max Macaluso, Ph.D.]
Health care analyst Max Macaluso recently sat down with Fool contributor Keith Speights to talk about some of the best speculative biotech plays on the market. Max and Keith discussed three companies that investors should consider: Keryx Pharmaceuticals (NASDAQ: KERX ) , Sarepta Therapeutics (NASDAQ: SRPT ) , and MannKind (NASDAQ: MNKD ) .
Top 10 Dow Dividend Companies To Watch In Right Now: Mistras Group Inc (MG)
Mistras Group, Inc. provides technology-enabled asset protection solutions to evaluate the structural integrity and reliability of critical energy, industrial, and public infrastructure worldwide. It provides traditional non-destructive testing (NDT) services; advanced NDT services; and mechanical integrity services. The company also offers software solutions, including Plant Condition Monitoring Software and Systems, an enterprise software that allows its customers for the warehousing and analysis of data. In addition, it provides Advanced Data Analysis Pattern Recognition and Neural Networks software, which enables acoustic emission (AE) experts to develop automated remote monitoring systems; AE Software Platform, a windows based real time application software; Loose Parts Monitoring Software program for monitoring, detecting, and evaluating metallic loose parts in nuclear reactor coolant systems; and Automated UT and Imaging Analysis Software for analyzing ultrasonic in spection data, and visualizing and identifying the location and size of flaws. Further, the company�s technology packages include TANKPAC for tank inspections; POWERPAC for monitoring discharges in critical power grid transformers; and Acoustic Combustion Turbine Monitoring System, an on-line system to detect stator blade cracks in gas turbines. Additionally, it offers digital radiographic systems to solve specific industrial problems; AE sensors, instruments, and turn-key systems, as well as leak monitoring and detection systems; ultrasonic equipment; vibration sensing products; and on-line monitoring services. Mistras Group, Inc. was founded in 1978 and is headquartered in Princeton Junction, New Jersey.
Advisors' Opinion:- [By Wallace Witkowski]
Stock in Mistras Group Inc. (MG) �rose 6.9% to $23.99 on light volume after the company raised its revenue outlook for the year to a range of $590 million to $615 million. Analysts expected $592.1 million.
- [By Monica Gerson]
Mistras Group (NYSE: MG) shares fell 7.71% to $20.47 after the company reported downbeat Q3 earnings and lowered its FY14 EBITDA forecast
WD-40 Company (NASDAQ: WDFC) slipped 5.58% to $73.48 after the company reported weaker-than-expected FQ2 earnings.
- [By Jake L'Ecuyer]
Mistras Group (NYSE: MG) shares tumbled 3.97 percent to $21.30 after the company reported downbeat Q3 earnings and lowered its FY14 EBITDA forecast.
Top 10 Dow Dividend Companies To Watch In Right Now: Dreyfus Strategic Municipal Bond Fund Inc (DSM)
Dreyfus Strategic Municipal Bond Fund, Inc. (the fund) is a diversified closed-end management investment company. The fund�� investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The Dreyfus Corporation serves as the fund�� investment adviser.
The fund invests at least 80% of its assets in municipal bonds. The fund also issues auction rate preferred stock and invests the proceeds in a manner consistent with its investment objective.
Advisors' Opinion:- [By Trista Kelley]
Cenkos Securities Plc (CNKS) is running the spinoff and the share sale. Royal DSM NV (DSM), the world�� largest maker of vitamins, holds about 9 percent of SiS, while U.K. venture-capital trust Downing LLP owns 16.7 percent, Moon said. Provexis stockholders received one share of Science in Sport for every 100 shares of Provexis.
No comments:
Post a Comment